SALT LAKE CITY, Feb. 11 /PRNewswire-FirstCall/ -- TechniScan, Inc.'s (OTC Bulletin Board: TSNI) cofounder and scientist-mathematician, James Wiskin, Ph.D, will be a presenting speaker at the SPIE Medical Imaging Conference in San Diego this weekend.
The TechniScan Warm Bath Ultra Sound (WBU™) system, capable of 3-dimensional whole breast imaging, is a result of Wiskin's and colleague David Borup's, Ph. D., groundbreaking work in the mathematics of inverse scattering. Wiskin will be presenting "Inverse Scattering and Refraction Corrected Reflection for Breast Imaging" to attendees of the SPIE conference at the Town and Country Resort & Convention Center.
SPIE is a non-profit international society for the exchange, collection and dissemination of knowledge in optics, photonics and imaging engineering. SPIE organizes conferences, courses and exhibitions covering many aspects and applications of modern technology.
"The WBU system is the culmination of many years of concentrated effort. We are pleased to present our state-of-the-art technology and scientific development to such a distinguished group," said David Robinson, the company's chief executive officer.
Wiskin is a cofounder and co-inventor of the fundamental imaging algorithms used by TechniScan to produce whole breast ultrasound images. His research includes inverse scattering theory, image processing; and acoustic, electromagnetic, and elastic wave propagation. His dissertation at the University of Utah (Mathematics) established new inverse scattering imaging methods. He currently holds a faculty position in the Department of Bioengineering at the University of Utah, where he has taught upper division courses since 1991.
About TechniScan, Inc.
Based in Salt Lake City, TechniScan, Inc. is a medical device company engaged in the development and commercialization of a non-invasive imaging tool designed to provide physicians with automated ultrasound images of the human breast. The system uses a process called Warm Bath Ultrasound (WBU ™) to provide physicians with automated, 3D, ultrasound images of the physical structures within the breast. TechniScan's WBU™ imaging device is limited by U.S. law to investigational use unless, and until, cleared by the FDA. For more information, please visit www.techniscanmedical.com.
Forward Looking Statements
Certain statements in this press release that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be identified by the use of words such as "anticipate, "believe," "expect," "future," "may," "will," "would," "should," "plan," "projected," "potential," "intend," and similar expressions. Such forward-looking statements, involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of TechniScan, Inc. (the "Company") to be materially different from those expressed or implied by such forward-looking statements. The Company's future operating results are dependent upon many factors, including risk factors discussed in the Company's periodic filings with the Securities and Exchange Commission, which are available for review at www.sec.gov, including the Company's Current Report on Form 8-K filed on October 16th, 2009. The Company undertakes no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.
SOURCE TechniScan, Inc.
|SOURCE TechniScan, Inc.|
Copyright©2010 PR Newswire.
All rights reserved